NCT06124625

Brief Summary

Infection with SARS-CoV-2 virus leads to persistent symptoms for more than 12 weeks in 15% of cases ("post-COVID syndrome"). Symptoms like fatigue, dyspnoea, limitations in physical performance and activities, head ache, anxiety symptoms, and depression are heterogenous which limit physical health and participation in daily life activities. In the last years, multidisciplinary rehabilitation programs showed benefits in quality of life and symptom intensity in patients with post-COVID. Therefore, rehabilitation programs are recommended for individuals with Post-COVID by official sites like the German Society of Pulmonology and the European Respiratory Society. Own first data (published at the ERS conference 2023) revealed that one the one hand, inpatient rehabilitation is effective, however, on the other hand, it is challenging to maintain these effects after completing the program. Therefore, the aim of this study is to sustain these benefits by using a digital maintenance program following the rehabilitation program compared to usual care.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 9, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 31, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

August 17, 2025

Status Verified

August 1, 2025

Enrollment Period

1.6 years

First QC Date

November 8, 2023

Last Update Submit

August 13, 2025

Conditions

Keywords

rehabilitationmaintenance program

Outcome Measures

Primary Outcomes (1)

  • Change from baseline quality of life assessed by Short-Form 12 questionnaire at week 4 and week 19

    The scale of the physical and mental Health component summary score ranges from minimum 0 to maximum 100 points with higher scores indicating better quality of life

    Baseline, week 4, week 19

Secondary Outcomes (17)

  • Change from baseline post-COVID-related symptoms at week 4 and week 19

    Baseline, week 4, week 19

  • Change from baseline lung function at week 4 and week 19

    Baseline, week 4, week 19

  • Change from baseline fatigue symptoms at week 4 and week 19

    Baseline, week 4, week 19

  • Change from baseline exercise capacity at week 4 and week 19

    Baseline, week 4, week 19

  • Change from baseline physical activity at week 4 and week 19

    Baseline, week 4, week 19

  • +12 more secondary outcomes

Study Arms (2)

Rehabilitation maintenance program

ACTIVE COMPARATOR
Procedure: Rehabilitation combined to a digital maintenance program

No Rehabilitation maintenance program

PLACEBO COMPARATOR
Procedure: Rehabilitation without maintenance program

Interventions

Individuals in this group undergo a 3-week inpatient rehabilitation program followed by a 12-week maintenance program (2 sessions per week à 90 minutes, digital and live). The multimodal programs consist of physiotherapy, training therapy, medical support, cognitive training, education and psychological support.

Rehabilitation maintenance program

Individuals in this group undergo a 3-week inpatient rehabilitation program followed by a 12-week usual care period.

No Rehabilitation maintenance program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Post-COVID-syndrome (Definition WHO)
  • Entered the rehabilitation process at the Schoen Klinik Berchtesgadener Land

You may not qualify if:

  • No internet access

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schone Klinik Berchtesgadener Land

Schönau am Königssee, 83471, Germany

Location

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Andreas R Koczulla, PROF

    Schön Klinik Berchtesgadener Land

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of pulmonology, head of institute for pulmonary rehabilitation research

Study Record Dates

First Submitted

November 8, 2023

First Posted

November 9, 2023

Study Start

January 31, 2024

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

August 17, 2025

Record last verified: 2025-08

Locations